Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 1/2 1

Status

Recruiting 4Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Pancreatic Neoplasms 54Biliary Tract Neoplasms 23Nasopharyngeal Carcinoma 22Carcinoma, Non-Small-Cell Lung 22Cholangiocarcinoma 21Urinary Bladder Neoplasms 18Breast Neoplasms 18Neoplasm Metastasis 17Lung Neoplasms 14Lymphoma, Large B-Cell, Diffuse 13Colorectal Neoplasms 12Carcinoma, Transitional Cell 12Non-Muscle Invasive Bladder Neoplasms 10Recurrence 8Ovarian Neoplasms 8Triple Negative Breast Neoplasms 7Sarcoma 7Neoplasms 6Hodgkin Disease 6Gallbladder Neoplasms 6Nasopharyngeal Neoplasms 5Bile Duct Neoplasms 5Adenocarcinoma 5Uterine Cervical Neoplasms 4Locally Advanced Pancreatic Cancer 4Endometrial Neoplasms 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Pancreatic Adenocarcinoma 3Osteosarcoma 3Lymphoma 3

Interventions

Gemcitabine 4130-nm albumin-bound paclitaxel 2Tomography, X-Ray Computed 1Pancreatectomy 1Endoscopy 1Electroporation 1Drug Therapy 1Diagnostic Imaging 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Locally Advanced Pancreatic Cancer × Gemcitabine × Clear all
NCT03652428 2026-05-06

Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)

University of Maryland, Baltimore

Phase 1/2 Recruiting
24 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

NCT03257033 2025-11-14

TIGeR-PaC

RenovoRx

Phase 3 Recruiting
190 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

NCT05653453 2025-03-24

Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer

Jiangsu Healthy Life Innovation Medical Technology Co., Ltd

Phase 3 Recruiting
512 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

NCT06494514 2024-07-10

NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase NA Recruiting
40 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡